Connect with us

Health

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities – News-Medical.Net

The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications…

Published

on

Article feature image

The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).
In a review article in Trends in Cancer, the team presented evidence that immunotherapies such as immune checkpoint inhibitors (which enable T cells to attack and kill cancer…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

It’s on our plates and in our poo, but are microplastics a health risk? – The Guardian
Article feature image
How does brain memorise familiar places – Big News Network